Results 141 to 147 of about 4,487 (147)

[Tenofovir amibufenamide treatment in a case of hepatitis B virus-related decompensated liver cirrhosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li YP, Gou GE, Dang SS.
europepmc   +1 more source

[Current status of research on the impairment of natural killer cell function caused by hepatitis B virus infection]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhu XY, Zhou YF, Zhu SG.
europepmc   +1 more source

[Expert opinions on the technical guiding principles for clinical trials of drugs in the treatment of chronic hepatitis B virus infection]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Author Group of Expert Opinions.
europepmc   +1 more source

[Real-world study of tenofovir amibufenamide in the treatment of patients with hepatitis B cirrhosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Han Y, Zeng AJ, Liang XY, Liu YN, Jin KK, Ding HG.   +5 more
europepmc   +1 more source

[Altered oral microbiome and metabolites are associated with improved lipid metabolism in HBV-infected patients with metabolic dysfunction-associated fatty liver disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhang J, Feng S, Zhang D, Xue J, Zhou C, Liu P, Fu S, Gong M, Feng H, Zhang N.   +9 more
europepmc   +1 more source

[A case of treated chronic hepatitis B reducing viral load with tenofovir amibufenamide treatment]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Yang X, Cao LF.
europepmc   +1 more source

[Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chen SY, Shan S, Kong YY, Xu XQ, Wang H, Wu XN, Zhou JL, Wang BQ, Meng TT, Zhang MY, Jia JD, Sun YM, You H.   +12 more
europepmc   +1 more source